References Peer Reviewed Sikiric P et al
At our Doral, FL clinic, we do not typically see patients lose weight or experience meaningful appetite changes as a primary effect of GHK-Cu therapy
For researchers investigating cellular senescence, aging biology, regenerative medicine, and age-related diseases, FOXO4-DRI offers a sophisticated tool that combines mechanistic precision with practical utility, enabling advancement in our understanding of senescence biology and the development of innovative approaches to studying aging and developing research tools for age-related cellular dysfunction
Dual Mechanism of Action: CagriSema combines two powerful weight-loss mechanisms: Cagrilintide, which mimics amylin, enhances satiety, and slows gastric emptying
Indirectly reduces ghrelin spikes